In addition to demonstrating upregulation of the Mertk pathway via single-cell sequencing of Aβo-injected AD mice, we further validated the underlying mechanism in vivo using both the Aβo injection model and 4-month-old 3xTg-AD mice. This evidence concerns the gene MERTK and Alzheimer disease.